Predicting cytomegalovirus infection and graft-versus-host disease using QuantiFERON-CMV and Monitor in pediatric transplants: a proof-of-concept study
Background: Cytomegalovirus (CMV) infection can lead to significant morbidity and mortality in pediatric hematopoietic stem cell transplant recipients. Early detection of CMV infection is crucial for managing its impact. Aim: This study aims to evaluate the effectiveness of QuantiFERON-CMV ® (QF-CMV...
Saved in:
Main Authors: | Lina Souan, Rawad Rihani, Maher A. Sughayer |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-02-01
|
Series: | Therapeutic Advances in Hematology |
Online Access: | https://doi.org/10.1177/20406207251316680 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing
by: J.S. Zifodya, et al.
Published: (2024-05-01) -
Incidence of ophthalmic manifestations in congenital cytomegalovirus (CMV)
by: Jennifer L. Rossen, et al.
Published: (2025-01-01) -
Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
by: Heinrike Wilkens, et al.
Published: (2016-01-01) -
Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
by: Samir J. Patel, et al.
Published: (2014-01-01) -
The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
by: Adewunmi Akingbola, et al.
Published: (2025-12-01)